Westlake Chemical Partners LP current report, 16 November 2017

Westlake Chemical Partners LP - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Westlake Chemical Partners LP on November 16, 2017. The report addresses a corporate governance amendment rather than a standard financial reporting period.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document does not contain financial statements or performance metrics.

Material Changes

On November 16, 2017, the General Partner, Westlake Chemical Partners GP LLC, entered into Amendment No. 1 to the First Amended and Restated Agreement of Limited Partnership. This amendment was enacted in response to changes in the Internal Revenue Code under the Bipartisan Budget Act of 2015 (BBA) regarding partnership audit and adjustment procedures. The amendment is effective as of November 16, 2017.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook. The primary context is regulatory compliance with new tax audit procedures. No specific risks or contingencies beyond the implementation of the partnership agreement amendment are detailed in this text.

Investor Verification Checklist

  • Review the full text of Amendment No. 1 (Exhibit 3.1) to understand specific changes to partnership audit procedures.
  • Verify the impact of the Bipartisan Budget Act of 2015 on the partnership's tax liability and audit obligations.
  • Confirm that no other material events were omitted from this specific 8-K filing.